Medtronic plc (MDTC34) — Cash Flow Reinvestment Rate

Latest as of January 2026: 0.37x

Medtronic plc (MDTC34) has a Cash Flow Reinvestment Rate of 0.37x as of January 2026, reinvesting R$1.76 Billion (capex R$1.42 Billion plus investments R$-347.00 Million) from operating cash flow of R$4.76 Billion. Explore MDTC34 capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

0.37x
(Capex + Investments) / Operating CF

Total Reinvested

R$1.76 Billion
Capex + Investments

Operating Cash Flow

R$4.76 Billion
BRL

Capital Expenditures

R$1.42 Billion
BRL

Medtronic plc Cash Flow Reinvestment Rate (2019–2025)

Historical reinvestment intensity for Medtronic plc across 7 annual periods. Also explore Medtronic plc (MDTC34) total assets for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for Medtronic plc (2019–2025)

Year-by-year capital reinvestment analysis for Medtronic plc. For live market cap and broader valuation context, see Medtronic plc market cap and net worth.

Year Reinvestment Rate Total Reinvested (BRL) Operating CF Capex YoY Change
2025 0.54x R$3.80 Billion R$7.04 Billion R$1.86 Billion ▼ -7.5%
2024 0.58x R$3.95 Billion R$6.79 Billion R$1.59 Billion ▼ -29.0%
2023 0.82x R$4.95 Billion R$6.04 Billion R$1.46 Billion ▲ +286.6%
2022 0.21x R$1.56 Billion R$7.35 Billion R$1.37 Billion ▼ -27.2%
2021 0.29x R$1.82 Billion R$6.24 Billion R$1.35 Billion ▼ -21.3%
2020 0.37x R$2.68 Billion R$7.23 Billion R$1.21 Billion ▼ -21.0%
2019 0.47x R$3.29 Billion R$7.01 Billion R$1.13 Billion
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow